Jump to:

Patient Resources

Display:
A - Z All Fact Sheets
Travel Fact Sheets

Leptospirosis (Weil's Disease)

Leptospirosis is a bacterial infection that can cause a range of symptoms. The common signs include fever, headache, and muscle pain. If left untreated, meningitis and liver / kidney damage (Weil's disease) may develop. Rarely leptospirosis can lead to death. This disease is found world-wide (except for Polar Regions).

How do you catch Leptospirosis?

Humans become infected through contact with water or soil containing urine from infected animals. This may occur when the infected water or soil comes into contact with broken skin or mucosal surfaces, such as the eyes or nose. Swallowing contaminated food or water has also been shown to cause leptospirosis. It is a recreational hazard for those who participate in outdoor sports in contaminated areas and has been associated with swimming, canoeing and white-water rafting in contaminated lakes and rivers.

Incubation period:

The time from exposure to the bacteria to developing symptoms is usually 4-19 days.

Diagnosis:

Diagnosis can be difficult and is usually confirmed by blood or urine tests.

Prevention:

Avoid swimming and wading in potentially contaminated water and wear protective clothing when work requires such exposure.

Treatment:

Antibiotic treatments such as doxycycline and penicillin are available. These treatments should be commenced promptly, seek medical attention early if you develop symptoms of this disease.

Fact sheet written by:

MASTA

MASTA are specialists in travel health services. Healthcare professionals can access its daily updated database of vaccine and travel health advice by registering at www.masta.org (fee applies). Travellers can search for advice and information and find a MASTA Travel Clinic at www.masta-travel-health.com

Latest Guidelines

Infliximab (review) and adalimumab for the treatment of Crohn's disease

Technology Appraisal Guidance No. 187 Source: National Institute for Health and...

Febuxostat for the Management of Hyperuricaemia in People with Gout

Technology Appraisal Guidance No. 164 Source: National Institute for Health and Clinical...

Trabectedin for the Treatment of Advanced Soft Tissue Sarcoma

Technology Appraisal Guidance No. 185 Source: National Institute for Health and Clinical...

Certolizumab Pegol for the Treatment of Rheumatoid Arthritis

Technology Appraisal Guidance No. 186 Source: National Institute for Health and Clinical...

Topotecan for the Treatment of Relapsed Small-Cell Lung Cancer

Technology Appraisal Guidance No. 184 Source: National Institute for Health and Clinical...

 

GP Curriculum Centre

Educational resource for the learning and teaching of the
GP curriculum

Click here to read more

Deleted products

Cumulative list of products discontinued from the UK market
in 2010

Click here to read more

Treating psoriasis

Healthcare Republic resource centre for diagnosing and managing psoriasis

Click here to read more

MIMs Drug Search

Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.

Find drugs by:

 

Back to top